From Concept to Commercialization

Select a stage to discover the breadth of L3 services:

Concept

Market intel to move your idea from concept to development

Development

Quality market inputs to drive the successful development of your product

Validation

Experienced resources to guide and execute clinical, regulatory and product validation

Launch

Pre-launch preparation to post-launch surveillance, our experience and expertise can help streamline market introductions

Commercialization

Effective strategies and tools to accelerate market adoption in the U.S. and beyond

Your Team

Lauren Lee (Geisbert) Lehman

Partner

Kirsten Dorsey

Partner, Director of Operations

Lara Brandon Poznak, CCRA

Clinical Trial Manager

Erika Lisanti

Operations Manager

Rosemary Eynck

Marketing Coordinator

Cheryl Kierce

Administrative Coordinator

Why Companies Love Working with L3

I Will Use L3 Healthcare Again

We were referred to L3 Healthcare by a friend and were pleasantly surprised by how amazing they were. We are a small start-up company and our budget is somewhat limited but Stacey with L3 found a way to make it work for us. It means the world that she was able to find a number that we could both work with and this will definitely be a long-term relationship because of that. The customer care, quality of work, and efficiency of delivery are all reasons why I will use L3 Healthcare again.

Phene Wardlaw Unity Beverage

Clinical Research Organization

L3 is extremely creative and flexible in helping small companies plan, budget, and conduct internal and external performance validations on our in vitro diagnostic instruments and assays. Read More>>

Kim Walker, MS, RAC (US & EU), FRAPS VP, Regulatory, Quality, and Clinical Affairs, Hycor Biomedical

EDC Design & Configuration

I would highly recommend evaluating iMedNet and allowing L3 to design and configure the system. Read More>>

Christopher L. Emery, M.D., D. (ABMM) Director, In Vitro Diagnostics Development and Clinical Trials Group, Indiana University Department of Pathology and Laboratory Medicine

Innovative Design

L3 was able to take a startup budget and deliver a design aesthetic of a Fortune 500. Read More>>

Han Chen CEO, ZeaKal, Inc.

High Quality Clinical Tools

L3 provided high quality educational and promotional tools for our target clinical audience. Read More>>

Scott Mader President & CEO, Clindevor 360